Trattamento transcatetere del dotto arterioso pervio

Translated title of the contribution: Transcatheter management of patent ductus arteriosus

Massimo Chessa, Bamoshmoosh Mohamed, Sandra Giusti, Gianfranco Butera, Roberta Margherita Bini, Nicola Carano, Aldo Agnetti, Umberto Squarcia, Giovanna Di Gregorio, Mario Carminati

Research output: Contribution to journalArticlepeer-review


Isolated patent ductus arteriosus accounts for 10 to 18% of all cardiovascular malformations. Transcatheter closure of the patent ductus arteriosus has now become established practice with a high success rate and a low incidence of complications. Many devices have been proposed during the last 20 years. The use of some of these devices has largely been abandoned for different reasons: high costs, the need of large transvenous sheaths and the high incidence of late residual shunts. The devices currently available (Amplatzer duct occluder, buttoned device, DuctOcclud coil, Gianturco-Grifka vascular occlusion device, detachable coils) render the embolization of a patent ductus arteriosus relatively easy, with a short hospital stay. We feel that this is the treatment of choice for the majority of patients with a patent ductus arteriosus. The aim of this article was to review our experience and report the state-of-the-art in transcatheter patent ductus arteriosus therapy.

Translated title of the contributionTranscatheter management of patent ductus arteriosus
Original languageItalian
Pages (from-to)1092-1097
Number of pages6
JournalItalian Heart Journal Supplement
Issue number11
Publication statusPublished - Nov 2002

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Transcatheter management of patent ductus arteriosus'. Together they form a unique fingerprint.

Cite this